TARO PHARM INDS LTD
GenericsTARO PHARM INDS LTD is a generic drug manufacturer focused on Neurology, Cardiovascular, Immunology.
TARO PHARM INDS LTD's Key Drugs
TARO PHARM INDS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
TARO PHARM INDS LTD's Recent FDA Approvals
New NDA/BLA approvals for TARO PHARM INDS LTD over the last two years — novel drugs only, excluding generics and label supplements.
TARO PHARM INDS LTD's Therapeutic Areas
TARO PHARM INDS LTD's approved drugs and pipeline span 4 therapeutic areas, led by Neurology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
TARO PHARM INDS LTD's Top Competitors
TARO PHARM INDS LTD's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Eli Lilly, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
TARO PHARM INDS LTD Pipeline Snapshot
Active clinical trials for TARO PHARM INDS LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1998-03-11
- Latest
- 2026-04-01
- Applications
- 13